DUBLIN, Oct. 31, 2019 /PRNewswire/ -- The "Subcutaneous Drug Delivery Devices Market to 2027 - Global Analysis and Forecasts by Technology; Syringe Type; Distribution Channel and Geography" report has been added to ResearchAndMarkets.com's offering.
The global subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.
The increased number of chronic disease prevalence around the globe, significant number of vaccination and immunization programs that incorporate the use of subcutaneous drug delivery devices for therapeutic administration, rise in the research and development of new products leading to the subsequent introduction of novel solutions and devices in the market are expected to account for the growth of the market. However, risk of infections and other diseases associated with the use of injections and syringes is likely to hamper the market growth.
Research and development (R&D) is an essential and crucial part of the company's business. Pharmaceutical and medical devices companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. R&D spending by the biopharmaceutical companies has also increased over the years.
According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion 2012 to US$ 58.8 billion in 2015. Also, Evonik Corporation has invested more than $50 million over the last 4 years to advance its competencies in medical devices, and production of RESOMER polymers for drug delivery and bio-reabsorbable medical devices. Thus the growing R&D expenditure drives the subcutaneous drug delivery systems market during the forecast period.
The global subcutaneous drug delivery devices market, based on the technology was segmented into syringes, pens, patches and others. In 2018, the syringes segment held the largest share of the market, by technology. However, the patches segmented is anticipated to witness fastest growth in the subcutaneous drug delivery devices market, based on technology. In the recent years, the increasing use of single-use syringes have helped to successfully reduce the rates of cross contamination thereby propelling the growth of syringes in the subcutaneous drug delivery devices market in the coming years.
Key Topics Covered:
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
2. Global Subcutaneous Drug Delivery Devices Market - Key Takeaways
3. Research Methodology
4. Global Subcutaneous Drug Delivery Devices- Market Landscape
4.2 PEST Analysis
4.3 Expert Opinions
5. Global Subcutaneous Drug Delivery Devices Market - Key Industry Dynamics
5.1.1 Increasing Incidence of Chronic Diseases
5.1.2 Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies
5.1.3 Technological Advancements and Increasing Product Launches
5.2 Key Market Restraints
5.2.1 Risks Associated with Injections:
5.3 Key Market Opportunities
5.3.1 Development of Products As Per Patient Compliance
5.4 Future Trends
5.4.1 Growing Product Innovations through Collaborative Research:
5.4.2 Rapid Adoption of Pre-Filled Saline Syringes
5.5 Impact Analysis
6. Subcutaneous Drug Delivery Devices Market - Global Analysis
6.1 Global Subcutaneous Drug Delivery Devices Market Revenue Forecasts And Analysis
6.2 Global Subcutaneous Drug Delivery Devices Market, By Geography - Forecasts And Analysis
6.3 Market Positioning of Key Players
7. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Technology
7.2 Global Subcutaneous Drug Delivery Devices Market Share by Technology 2018 & 2027 (%)
7.3 Syringes Market
8. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Syringe Type
8.2 Global Subcutaneous Drug Delivery Devices Market Share by Syringe Type 2018 & 2027 (%)
8.3 Prefilled Injectable Market
8.4 Fillable Injectable Market
9. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Distribution Channel
9.2 Global Subcutaneous Drug Delivery Devices Market Share by Distribution Channel 2018 & 2027 (%)
9.3 Hospital Pharmacies Market
9.4 Retail Pharmacies Market
9.5 Online Pharmacies Market
10. Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 - Geographical Analysis
Key Company Profiles
- Insulet Corporation
- Enable Injections
- Consort Medical Plc
- West Pharmaceutical Services, Inc.
- Elcam Medical
- Ypsomed AG
- SCPharmaceuticals, Inc.
- Wilhelm Haselmeier GmbH & Co. KG
For more information about this report visit https://www.researchandmarkets.com/r/14h03l
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716